Dubermatinib(TP-0903)

製品コードS7846 バッチS784603

印刷

化学情報

Synonyms

N/A

Storage
(From the date of receipt)

3 years -20°C powder
1 years -80°C in solvent

化学式

C₂₄H₃₀ClN₇O₂S

分子量

516.06

CAS No.

1341200-45-0

Solubility (25°C)*

体外

DMSO (warmed with 50ºC water bath)

10 mg/mL (19.37 mM)

Ethanol (warmed with 50ºC water bath)

1 mg/mL (1.93 mM)

Water

Insoluble

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension

CMC-NA

≥5mg/ml

Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	TP-0903 is a potent and selective AXL Inhibitor with IC50 of 27 nM. TP-0903 is highly effective in inducing apoptosis.
in vitro	In pancreatic cancer cells (PSN-1), Dubermatinib (TP-0903) shows strong antiproliferative activity with IC50 of 6 M. It also induces strong G2/M arrest by potently inhibiting Aurora A and B. [1] In CLL B cells from all the patients with CLL, this compound causes a dose-dependent induction of massive apoptosis by targeting phosphorylated Axl, and overcomes CLL BMSC-mediated protection of CLL B cells from apoptosis. ^[2]
in vivo	Dubermatinib (TP-0903), when administered intracerebroventricularly at 2.5 nM in the adult rat hippocampus, significantly increases the number of newly generated cells and extends survival of hippocampal cells. ^[3] In mice, this compound (20 μg/g, i.p.) effectively prevents GC-induced neonatal cerebellar developmental abnormalities. ^[4]

プロトコル(参考用のみ)

キナーゼアッセイ	Axl Kinase activity assay
キナーゼアッセイ	Test compounds, including Dubermatinib (TP-0903), are diluted to desired concentrations in kinase reaction buffer (50 mM HEPES pH 7.5, 10 mM MgCl², 1 mM EGTA, 2 mM DTT, and 0.01% v/v Tween-20) and are briefly incubated with Axl kinase. The Axl kinase used is recombinant human Axl kinase (catalytic domain, amino acids 473-894) with a histidine tag. The reaction is initiated by the addition of ATP and labeled poly-GT substrate (poly Glu:Tyr, 4:1 polymer). Concentration of the various components in the assay (10 µL reaction volume) are: 1% DMSO, 93 ng/mL Axl kinase, 20 µM ATP, and 200 nM poly-GT substrate. Following addition of ATP and poly-GT substrate, incubation is for 60 min at room temperature, the enzyme reaction is stopped by addition of 10 µL terbium-labeled anti-phosphotyrosine PY20 antibody in EDTA-containing buffer. Final concentration of EDTA and antibody after addition to the reaction is 10 mM and 2 nM, respectively. The terbium conjugated antibody generates a time-resolved FRET signal with the molecule (bound to the poly-GT substrate) when the substrate is phosphorylated. After one hour incubation at room temperature, fluorescence is measured with excitation of 320 nm and dual emission of 495 and 520 nm on an EnVision microplate reader. Signal is expressed in terms of a TR-FRET ratio (fluorescence intensity at 520 nm to 495 nm).
細胞アッセイ	細胞株	PSN-1 cells
	濃度	--
	反応時間	96 hours
	実験の流れ	For cell proliferation assays with Dubermatinib (TP-0903), 45 µL containing 1000 cells per well are seeded into solid white 384-well plates in appropriate cell growth media containing 10% FBS and incubated overnight at 37 °C and 5% CO₂. The following day, this compound is diluted in serum free growth media to 10x desired concentrations and 5 µL is added to each well. Combined compound and cells are incubated for 96 hours. Following incubation, 40 µL of ATP-Lite solution is added to each well, incubated for an additional 10 minutes at room temperature and luminescence is measured on an EnVision microplate reader. Percent cell viability for it is calculated by comparing treated wells to appropriate controls (e.g. vehicle treated) included on each plate.

参考

https://pubmed.ncbi.nlm.nih.gov/22247788/
https://pubmed.ncbi.nlm.nih.gov/25673699/

カスタマーフィードバック

: Data from [Data independently produced by , , Sci Rep, 2017, 7(1):10613]

: Data from [Data independently produced by , , Cancer Cell Int, 2018, 18:63]

: Data from [Data independently produced by , , Eur J Pharmacol, 2018, 818:435-448]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

TP-0903 Suppresses Aurora A-PLK1 Signaling to Inhibit Proliferation of a Myelodysplastic Syndrome-Derived Cell Line [ Cancer Sci, 2025, 10.1111/cas.70151]	PubMed: 40722126
In vitro synergistic effect of AXL, FAK and ErbB receptors inhibitors for head and neck cancer [ Biol Direct, 2025, 20(1):77]	PubMed: 40605022
Targeting rapid TKI-induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3/ITD acute myeloid leukemia [ Mol Oncol, 2024, 10.1002/1878-0261.13749]	PubMed: 39395205
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages [ Cell Rep, 2023, 42(9):113067]	PubMed: 37659081
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer [ Sci Adv, 2022, 8(20):eabk2746]	PubMed: 35594351
DETERMINING THE MECHANISMS BEHIND ADAPTIVE RESISTANCE IN FLT3/ITD AML [ Johns Hopkins University, 2022, ]	PubMed: None
Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms [ Cancer Cell, 2021, S1535-6108(21)00492-X]	PubMed: 34624218
Gas6/Axl signaling pathway promotes proliferation, migration and invasion and inhibits apoptosis in A549 cells [ Exp Ther Med, 2021, 22(5):1321]	PubMed: 34630675
Synthetic Lethal and Resistance Interactions With BET Bromodomain Inhibitors in Triple-Negative Breast Cancer [ Mol Cell, 2020, 7;S1097-2765(20)30269-0]	PubMed: 32416067
Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway [ J Exp Clin Cancer Res, 2020, 39(1):197]	PubMed: 32962728

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。